Search research articles
Contact Us
Filters
Showing results (91-100 of 322) with videos related to
Page
of 33
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 19, 2004
Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphoma
Koen Van Besien, Rakesh Mehra, Navin Wadehra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 8, 2009
BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplants
Peter H O'Donnell, Kate Swanson, Michelle A Josephson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2008
A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies
David A Rizzieri, Eric Feldman, John F Dipersio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2004
Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignancies
Todd M Zimmerman, Helena Harlin, Olatoyosi M Odenike, et al.
Blood Cancer Journal
|
March 4, 2021
OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia
Bartholomew J Eisfelder, Caner Saygin, Joseph Wynne, et al.
Leukemia Research
|
August 5, 2014
Genomic aberrations in myeloid sarcoma without blood or bone marrow involvement: characterization of formalin-fixed paraffin-embedded samples by chromosomal microarrays
M Kamran Mirza, Madina Sukhanova, Friedrich Stölzel, et al.
Leukemia Research
|
October 16, 2015
Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia
Geoffrey L Uy, Yen-Michael S Hsu, Amy P Schmidt, et al.
Leukemia & Lymphoma
|
October 14, 2009
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence
Koen van Besien, Alexander Dew, Shang Lin, et al.
Chest
|
September 12, 2017
De Novo Development of Bronchiectasis in Patients With Hematologic Malignancy
Lena W Chen, Pamela J McShane, William Karkowsky, et al.
Leukemia & Lymphoma
|
April 15, 2003
Treatment of the chronic phase of chronic myeloid leukemia with an intermittent schedule of recombinant interferon alfa-2b and cytarabine: results from CALGB study 9013
Richard T Silver, Bercedis L Peterson, Ted P Szatrowski, et al.
Page
of 33
Search research articles
Search
Showing results (91-100 of 322) with videos related to
Sort By:
Page
of 33
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 19, 2004
Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphoma
Koen Van Besien, Rakesh Mehra, Navin Wadehra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 8, 2009
BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplants
Peter H O'Donnell, Kate Swanson, Michelle A Josephson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2008
A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies
David A Rizzieri, Eric Feldman, John F Dipersio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2004
Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignancies
Todd M Zimmerman, Helena Harlin, Olatoyosi M Odenike, et al.
Blood Cancer Journal
|
March 4, 2021
OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia
Bartholomew J Eisfelder, Caner Saygin, Joseph Wynne, et al.
Leukemia Research
|
August 5, 2014
Genomic aberrations in myeloid sarcoma without blood or bone marrow involvement: characterization of formalin-fixed paraffin-embedded samples by chromosomal microarrays
M Kamran Mirza, Madina Sukhanova, Friedrich Stölzel, et al.
Leukemia Research
|
October 16, 2015
Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia
Geoffrey L Uy, Yen-Michael S Hsu, Amy P Schmidt, et al.
Leukemia & Lymphoma
|
October 14, 2009
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence
Koen van Besien, Alexander Dew, Shang Lin, et al.
Chest
|
September 12, 2017
De Novo Development of Bronchiectasis in Patients With Hematologic Malignancy
Lena W Chen, Pamela J McShane, William Karkowsky, et al.
Leukemia & Lymphoma
|
April 15, 2003
Treatment of the chronic phase of chronic myeloid leukemia with an intermittent schedule of recombinant interferon alfa-2b and cytarabine: results from CALGB study 9013
Richard T Silver, Bercedis L Peterson, Ted P Szatrowski, et al.
Page
of 33